Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 816Session 2026

What changed between versions

10 paragraphs changed+4 words added−15 removed

Highlighted text was added in the newer version. Struck-through text was removed.

Florida Senate

-

ENROLLED

2026

Legislature

SB 816

By

Senator Bradley

6-01133-26 2026816__

1 A bill to be entitled

2026816er

1

2 An act relating to diabetes research; creating s.

185 unchanged paragraphs

3 1004.562, F.S.; establishing the University of Florida

4 Diabetes Institute within the University of Florida

5 College of Medicine; providing the purpose of the

6 institute; providing requirements for the institute;

7 authorizing the institute to administer statewide

8 pilot programs; requiring the institute to maintain a

9 secure repository for deidentified data; authorizing

10 the institute to share deidentified data under certain

11 conditions; authorizing the institute to convene a

12 consortium; providing requirements for the consortium;

13 authorizing the consortium to solicit funding from

14 certain sources for certain purposes; requiring the

15 institute to provide a report to the Governor and the

16 Legislature beginning on a specified date and annually

17 thereafter; providing requirements for the report;

18 providing construction; providing an effective date.

19

20 Be It Enacted by the Legislature of the State of Florida:

21

22 Section 1. Section 1004.562, Florida Statutes, is created

23 to read:

24

1004.5

6

2 University of Florida Diabetes Institute.—

25

(1)

The University of Florida Diabetes Institute is

26

established within the University of

Florida College of Medicine

27

as

a

resource for diabetes research, screening, prevention,

28

treatment, and education. The purpose of the institute is to

29

advance scientific discovery, improve prevention and clinical

30

care, and promote education and outreach related to all forms of

31

diabetes, including type 1 diabetes, type 2 diabetes,

32

gestational diabetes, and related metabolic conditions.

33

(2)

The institute shall do all of the following:

34

(a)

Conduct research to understand the causes, mechanisms,

35

and potential cures for diabetes, including autoimmune, genetic,

36

and environmental factors.

37

(b)

Develop advanced prevention, diagnostic, and treatment

38

strategies to reduce the incidence and complications of diabetes

39

in children and adults.

40

(c)

Provide comprehensive, multidisciplinary clinical care

41

to individuals living with diabetes, including patient and

42

family education, nutrition counseling, mental health support,

43

and disease management resources.

44

(d)

Train and educate health care professionals, including

45

physicians, nurses, dietitians, pharmacists, and scientists, to

46

expand expertise in diabetes care and research.

47

(e)

Establish collaborations with state universities,

48

medical centers, patient advocacy groups, community

49

organizations, and government agencies to enhance care and

50

accelerate progress toward diabetes prevention and cures.

51

(f)

Engage in community-based outreach and education

52

programs to increase awareness, reduce disparities in diabetes

53

outcomes, and promote healthier lifestyles.

54

(3)(a)

The institute may establish and administer statewide

55

pilot programs, including

,

but not limited to

,

population-based

56

diabetes screening, prevention initiatives, and technology

57

driven management tools.

58

(b)

The institute shall maintain a secure data repository

59

to collect, store, and analyze deidentified data for the purpose

60

of advancing diabetes research, prevention, and care.

61

(c)

The institute may provide deidentified data, pursuant

62

to data-sharing agreements, to research collaborators to support

63

ongoing and future scientific investigations.

64

(4)(a)

The institute may convene a statewide

d

iabetes

65

r

esearch and

c

are

c

onsortium composed of clinical and academic

66

experts, health care providers, and patient representatives to

67

coordinate research, share expertise, and develop innovative

68

care models.

69

(b)

The consortium shall

, upon being convened,

be

70

administered at the institute under the direction of the

71

institute’s executive leadership.

72

(c)

The consortium may solicit funding from public,

73

nonprofit, and private sources to expand programs, research

74

initiatives, and community services.

75

(5)

Beginning October 15, 2027, and annually thereafter,

76

the institute shall provide a report to the Governor, the

77

President of the Senate, and the Speaker of the House of

78

Representatives

which includes all of the following

:

79

(a)

Research projects and findings.

80

(b)

Clinical services provided and patient outcomes.

81

(c)

Community outreach and prevention initiatives.

82

(d)

Recommendations for future initiatives.

83

(6) T

his section shall be implemented to the extent of

84

appropriations provided in the annual General Appropriations Act

85

or from other available funds.

86 Section 2. This act shall take effect July 1, 2026.

Back to the full text